Charles Schwab Investment Management Inc Tg Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,269,513 shares of TGTX stock, worth $44.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,269,513
Previous 1,184,609
7.17%
Holding current value
$44.6 Million
Previous $27.7 Million
37.91%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding TGTX
# of Institutions
372Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$548 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$400 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$323 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$112 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$98.1 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.1B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...